References
- Monden Y, Sugita M, Yamakawa R, Nishimura K. Clinical experience treating Paecilomyces lilacinus keratitis in four patients. Clin Ophthalmol. 2012; 6: 949-53. PubMed | Google Scholar
- McLintock CA, Lee GA, Atkinson G. Management of recurrent Paecilomyces lilacinus keratitis. Clin Exp Optom. 2013; 96(3): 343-5. PubMed | Google Scholar
- Anderson KL, Mitra S, Salouti R, Pham TA, Taylor HR. Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea. 2004; 23(5): 516-21. PubMed | Google Scholar
- Costa SF, Alexander BD. Diagnosis and treatment of Scedosporium infection. http:// www.uptodate.com/ contents/diagnosis-and-treatment-of-scedosporium-infection. Accessed 7 September 2014. Google Scholar
- Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bödvarsson
M, Arnadottir M. Cutaneous infection by Paecilomyces lilacinus in a renal transplant:
treatment with voriconazole. Scand J Infect Dis. 2000; 32(3): 331-2. PubMed | Google
Scholar
- McLintock CA, Lee GA, Atkinson G. Management of recurrent Paecilomyces lilacinus keratitis. Clin Exp Optom. 2013; 96(3): 343-5. PubMed | Google Scholar
- Yuan X, Wilhelmus KR, Matoba AY, Alexandrakis G, Miller D, Huang AJW. Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol. 2009; 147(4): 691-6. PubMed | Google Scholar
- Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008; 126(1): 18-22. PubMed | Google Scholar
- Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA. Determination of vitreous, aqueous and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004; 122(1): 42-7. PubMed | Google Scholar
- Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 2004; 48(7): 2727-9. PubMed | Google Scholar